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Abstract
The use of cardiovascular magnetic resonance imaging left atrial late gadolinium enhancement (LA LGE) is increasing for 
fibrosis evaluation though the use is still limited to specialized centres due to complex image acquisition and lack of con-
sensus on image analyses. Analysis of LA LGE with image intensity ratio (IIR) (pixel intensity of atrial wall normalized 
by blood pool intensity) provides an objective method to obtain quantitative data on atrial fibrosis. A threshold between 
healthy myocardium and fibrosis of 1.2 has previously been established in 3T scans. The aim of the study was to reaffirm 
this threshold in 1.5T scans. LA LGE was performed using a 1.5T magnetic resonance scanner on: 11 lone-AF patients, 11 
age-matched healthy volunteers (aged 27–44) and 11 elderly patients without known history of AF but varying degrees of 
comorbidities. Mean values of IIR for all healthy volunteers +2SD were set as upper limit of normality and was reproduced 
to 1.21 and the original IIR-threshold of 1.20 was maintained. The degree of fibrosis in lone-AF patients [median 9.0% (IQR 
3.9–12.0)] was higher than in healthy volunteers [2.8% (1.3–8.3)] and even higher in elderly non-AF [20.1% (10.2–35.8), 
p = 0.001]. The previously established IIR-threshold of 1.2 was reaffirmed in 1.5T LA LGE scans. Patients with lone AF 
presented with increased degrees of atrial fibrosis compared to healthy volunteers in the same age-range. Elderly patients 
with no history of AF showed significantly higher degrees of fibrosis compared to both groups with younger individuals.
Keywords Cardiac magnetic resonance imaging · Left atrial late gadolinium enhancement · Image intensity ratio · Atrial 
fibroses · Atrial fibrillation
Introduction
The clinical demand for cardiac magnetic resonance imaging 
(CMR) and the corresponding scientific developments have 
been expanding during the past 20 years [1]. Late gado-
linium enhancement is today a well-established method for 
detecting fibrosis in the ventricular myocardium [2]. Since 
its introduction in 2007 [3], CMR imaging of left atrial 
fibrosis with late gadolinium enhancement (LA LGE) has 
received increasing interest [4–9]. The method has proven 
valuable in detection of pre-ablation atrial fibrosis [4, 8, 
10–13] but also in evaluation of ablation procedures and 
detection of possible gaps in ablation lines after pulmonary 
vein isolation [10, 12, 14–16].
Despite its many promising possibilities, LA LGE has 
remained a method reserved for highly specialized cen-
tres and previous studies have reported both positive [4, 8, 
14, 15] as well as disappointing results [5, 7, 16–19]. The 
clinical adoption of LA LGE has been slowed by complex 
image acquisition protocols reflected in high exclusion rates 
of scans in clinical studies (9–32%) [4, 5, 8, 9, 13, 20] and 
furthermore of a lack of consensus on an objective image 
analysis method [21]. Initially, fibrotic areas were evaluated 
visually [3] but the need for an objective analysis method 
resulted in development of various reference-based analysis 
methods. Different anatomic regions have been used as ref-
erence; healthy atrial myocardium [11], nulled ventricular 
myocardium [19], fibrotic atrial myocardium [14], blood 
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pool variability [12, 22] or blood intensity [23]. All methods 
aim to distinguish between healthy and fibrotic atrial myo-
cardium. As the interstitial fibrosis prior to ablation in other-
wise similar atrial fibrillation (AF) patient groups vary from 
6 to 31% [4, 5, 12, 18, 20, 24–27] and in healthy volunteers 
from 1.7 to 8.9% [11, 27] with various analysis methods, 
there is an obvious need for an objective analysis method 
for continuous development of LA LGE and for obtaining 
trustworthy clinical results.
The image intensity ratio (IIR) analysis method of LA 
LGE uses the mean blood volume intensity as reference [23, 
25]. By normalization with the mean blood pool intensity 
the variability due to timing and dose of contrast, renal func-
tion, coil proximity, and haematocrit is reduced and the IIR 
analysis method hence provides an objective assessment of 
LA LGE. The IIR analysis method was initially introduced 
by Khurram et al. who defined IIR thresholds based on elec-
troanatomic mapping (EAM) [23]. The IIR analysis method 
has shown good consistency and absolute agreement when 
compared to other thresholding methods [6]. Based on data 
from healthy volunteers Benito et al. found an upper IIR 
threshold of 1.2 for healthy atrial myocardium [25]. The 
study by Benito et al. was performed on 3 Tesla (T) mag-
netic resonance (MRI) scanners and so far, this threshold 
has not been validated or reproduced at 1.5T. Currently 1.5T 
scanners are more widely used than 3T scanners for cardiac 
MRI. Although available data suggest that the field strengths 
provide similar results [6], differences in signal-to-noise and 
contrast-to-noise between the two field strengths may result 
in differences in measured tissue intensities [28]. This means 
that a validation of the thresholds in both field strengths is 
important before using the thresholds in large scale studies 
or clinical work [25].
The aim of this study was to reproduce the LA LGE 
IIR threshold found at 3T for healthy atrial myocardium in 
healthy volunteers scanned on a 1.5T MRI scanner.
Methods
Study population
A total of 33 participants were included for the study: 11 
healthy volunteers, 11 patients with lone paroxysmal atrial 
fibrillation (AF) and 11 elderly patients.
The group of healthy volunteers served as reference for 
healthy tissue and were used for calculating the image inten-
sity ratio (IIR) threshold at 1.5T. This group consisted of 
11 healthy volunteers, age-matched to the below-mentioned 
lone AF patients. The healthy volunteers had no history of 
heart disease or other health conditions and did not receive 
prescription medication.
Two patient groups were included for verification of the 
threshold obtained: 11 patients with lone paroxysmal atrial 
fibrillation aged less than 45 years of age and no prior abla-
tions and 11 elderly patients (minimum 70 years of age) 
with no history of AF but with various degrees of known 
diabetes mellitus, hypertension, congestive heart disease 
and/or previous stroke.
Exclusion criteria for all included participants were glo-
merular filtration rate < 60 mL/min, claustrophobia, known 
gadolinium allergy and implanted ferromagnetic metals.
All included participants were scanned for research 
purposes and provided written informed consent prior to 
inclusion. The study protocol conforms to the ethical guide-
lines of the 1975 Declaration of Helsinki as reflected in a 
priori approval by the local ethics committee of the Capital 
Region of Denmark (Protocol Number H-1-2011-044 and 
H-4-2013-025).
Image acquisition
A 1.5T MRI scanner (Aera, Siemens Healthcare, Germany) 
with an 18-channel body coil was used to scan all included 
patients and healthy volunteers at Rigshospitalet, Copen-
hagen, Denmark. After scout sequences, long axis cine 
images (two-chamber, three-chamber and four-chamber) 
images were acquired for planning of a short axis stack and 
aid in delineation of chambers. An axial cine stack ranging 
from the basis to the aortic arch and a short axis cine stack 
covering the entire left ventricle were obtained for measure-
ment of left atrial and left ventricular volumes, respectively 
(steady-state free precession cine sequences (8 mm; 2 mm 
gap; 25 phases; field of view (320–360) × 360 adjusted for 
each patient; matrix size [182–224) × (138–224)] at 10–15 s 
end-expiratory breath-holds).
The left atrial late gadolinium enhancement (LA 
LGE) scan was performed 20 min after bolus injection of 
0.2 mmol/kg gadobutrol (Gadovist, Bayer, Berlin, Ger-
many), with a maximum of 15 mmol in total [6]. The LA 
LGE scan consisted of a free-breathing respiration-nav-
igator-gated 3D FLASH sequence with FatSat and ECG-
gating (atrial end-diastole, determined from four chamber 
cine). Typical parameters were TR/TE 4.67/1.94 ms and 
bandwidth of 300 Hz. Inversion time was set according to 
a scout-sequence in a mid-ventricular image (270–310 ms). 
Flip angle was 20° and slice thickness 1.5 mm. Pixel spac-
ing was 0.70 × 0.70 mm. No parallel-imaging was used. The 
mean acquisition time was 9 min 12 s ranging from 3 min 
12 s to 16 min 27 s.
Image analyses
Volumetric measurements were performed in  CVI42 (v. 
5.6.6, Circle Cardiovascular Imaging Inc., Calgary, Canada). 
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On short axis cine images left ventricular (LV) end-dias-
tolic and end-systolic phases were traced manually at the 
endo- and epicardial border. Left ventricular outflow tract 
(LVOT) was included in the blood pool; papillary muscles 
were excluded, using windowing for the endocardial bor-
der detection. Epicardium was delineated in both phases 
to compare left myocardial mass in end-diastole and end-
systole. Left atrial (LA) volumes were traced manually on 
axial cine images. Left atrial appendage was included in 
left atrial volume. Minimum and maximum volumes were 
indexed to body surface area.
LA LGE scans were analysed using ADAS ® image post-
processing software (Galgo Medical SL, Barcelona, Spain). 
On all axial images the atrial blood pool was initially seg-
mented and atrial wall was interpolated automatically into 
a 3D shell, which was manually adjusted. To avoid epi- or 
endocardial artefacts or partial volume effects, the software 
was set to create a single mid-myocardial layer, which was 
manually adjusted according to MRI images to represent 
mid-atrial wall. Inflow artefacts were excluded. Pulmonary 
veins and mitral valves were excluded for fibrosis analyses. 
Pixel intensities were calculated automatically and shown 
on the 3D shell. Atrial wall pixel intensities and mean blood 
pool intensity were exported from ADAS ®. Image intensity 
ratio (IIR) values of all atrial wall pixels were calculated 
as atrial wall pixel intensity divided by mean blood pool 
intensity) (see Fig. 1).
Image intensity ratio threshold
The threshold sought for was the discrimination between 
healthy and fibrotic atrial tissue. In accordance with Benito 
et al. [25], normal LA IIR was extracted from healthy vol-
unteer scans. All IIR values from healthy volunteers were 
plotted in a histogram and the upper limit of normality (i.e. 
the threshold value for normal atrial myocardium vs. fibrotic 
myocardium) was defined as the mean IIR value + 2 SDs.
Histograms of IIR-values for the two remaining groups 
were constructed and all three histograms were tested for 
skewness. Skewness-values close to zero represent sym-
metry, negative values represent left-tailed distributions 
and increasingly positive values represent increasingly 
right-tailed distributions. A right-tailed distribution would 
in this case represent increased degrees of fibrosis.
To investigate whether there was possible age-related 
fibrosis in the healthy control group we divided the group 
into a younger and older half based on median age and 
compared the thresholds in these two groups.
Detection of different degrees of native fibrosis
The obtained threshold distinguishing between healthy 
and fibrotic atrial wall was subsequently applied to the 
segmentations performed in ADAS ® to detect the degree 
of native fibrosis in the atrial wall in the three included 
groups. The degree of fibrosis was calculated as the per-
centage of pixels in the atrial wall above the set threshold.
Statistics
Continuous variables are presented as mean ± SD or 
median (interquartile range) and compared with one-way 
ANOVA/Kruskal–Wallis test. For pairwise comparisons, 
t-tests were performed. Non-normal distribution variables 
were logarithmically transformed and tested for normal-
ity prior to statistical tests. Inter- and intra-observer vari-
ability was performed in a subset of 15 randomly selected 
participants (five from each group). Intraclass correlation 
coefficient (ICC) was evaluated (good correlation was 
defined as ICC > 0.70). Bland–Altman plots were con-
structed and visually inspected for bias or proportional 
error. P-values < 0.05 were considered statistically sig-
nificant. All analyses were performed in SPSS Statistics 
(version 22, International Business Machines, Armonk, 
New York, USA).
Fig. 1  Example of left atrial late gadolinium enhancement image. A 
original image. Blood intensity is 60 and image intensity ratio thresh-
old hence (60 × 1.2 =) 72. B depicts segmented atrial wall, blue indi-
cating atrial wall below threshold, red indicating atrial wall above 
threshold. RA right atrium, LA left atrium, Eso esophagus, LV left 
ventricle, Ao aorta
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Results
Table 1 presents clinical baseline data for all included par-
ticipants. Healthy volunteers and lone AF patients were of 
similar age (37 SD 6 vs. 39 SD 5 years) and patients in 
the elderly non-AF group were 76 SD 5 years. None of the 
healthy volunteers or lone-AF patients had any history of 
hypertension, diabetes mellitus, congestive heart disease or 
previous stroke, whereas these conditions were present to a 
varying degree in the elderly group (18–82%).
Image intensity ratio threshold
In total, 308,877 pixel points were registered from healthy 
controls, 277,666 from lone AF patients and 314,393 from 
elderly non-AF patients and plotted as histograms (see 
Fig. 2).
Image intensity (IIR) threshold was extracted from 
healthy volunteer data (IIR mean + 2 SD) which was 1.21. 
When separating the healthy controls into an older and a 
younger fraction according to mean age, the IIR for < 37 
(n = 6) and > 37  years (n = 5) were 1.22 ± 0.07 versus 
1.21 ± 0.06 (p = 0.92).
The small deviation from the threshold set by Benito et al. 
[25] (1.20 vs. 1.21) was considered insignificant and hence 
for further analyses we performed the analyses with the IIR 
threshold value of 1.20.
Histograms of IIR-values for the three different groups 
showed skewness values of 0.16 for healthy controls, 0.20 
Table 1  Baseline data on all 
included volunteers and patients
AF atrial fibrillation, TIA transitory ischemic attack, other antihypertensives include ACE-inhibitors, angio-
tensin II receptor antagonists and calcium antagonists, ASA acetylsalicylic acid







Age (years) 37 ± 6 39 ± 5 76 ± 5
Male (%) 9 (82%) 10 (91%) 6 (55%)
Body surface area  (m2) 2.0 ± 0.1 2.1 ± 0.2 1.9 ± 0.2
Hypertension 0 0 9 (82%)
Diabetes mellitus 0 0 5 (45%)
Congestive heart disease 0 0 2 (18%)
Previous stroke/TIA 0 0 4 (36%)
Medication
 Beta blockers 0 0 1 (9%)
 Diuretics 0 0 5 (45%)
 Other antihypertensives 0 0 9 (82%)
 Antidiabetics 0 0 5 (45%)
 Statins 0 0 9 (82%)
 ASA and/or platelet-inhibitors 0 0 7 (64%)
Fig. 2  Histograms of image intensity ratios of the three different 
included groups. Notice the increasing right-sided skewness of lone 
AF and elderly non-AF. AF atrial fibrillation
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for lone AF patients and 0.70 for elderly non-AF patients, 
representing increasingly right-tailed distributions.
Detection of different degrees of native fibrosis
Subsequent analyses of the degree of fibrosis in the three 
groups with the IIR threshold of 1.20 revealed significantly 
different degrees of fibrosis with a median in healthy volun-
teers of 2.8% (1.3–8.3), lone-AF patients at 9.0% (3.9–12.0) 
and reaching the highest median value in elderly non-AF 
patients at 20.1% (10.2–35.8) (see Table 2). Table 2 shows 
conventional CMR variables. All measured CMR parameters 
were statistically similar between the three groups except for 
IIR-values and the degree of fibrosis.
Inter- and intra-observer agreement was excellent (inter-
observer ICC = 0.957 (95% CI 0.880, 0.985) and intra-
observer ICC = 0.995 (95% CI (0.986, 0.998). Bland–Altman 
plots are depicted in Fig. S1. Mean difference for inter-
observer agreement was − 1.7 limits of agreement (− 10.25, 
6.8) and for intra-observer − 1.0 (− 3.8, 1,7).
Discussion
The present study verifies the use of the image intensity 
ratio (IIR) threshold value of 1.20 distinguishing healthy 
from fibrotic atrial myocardium in 1.5T LA LGE scans. This 
threshold value has previously been established in 3T scans 
on healthy volunteers [25] but never in 1.5T scans. When 
using this threshold in analyses of two different patient 
groups and healthy volunteers we found that young lone-AF 
patients with paroxysmal AF had increased degrees of atrial 
fibrosis compared to healthy volunteers in the same age-
range. A group of elderly patients with no history of AF but 
various comorbidities that increases the risk of AF, revealed 
significantly increased degrees of atrial fibrosis compared to 
both other groups. This validation means that CMR studies 
of LA LGE performed on both 3T and 1.5T scanners can be 
analysed with the same threshold. This is also in line with 
the results by Chubb et al. [6] that LA LGE results in 1.5T 
and 3T are comparable.
The IIR analysis method was initially introduced by 
Khurram et al., who defined two IIR thresholds based on 
electroanatomic mapping (EAM): One at 0.97 distinguishing 
healthy myocardium from diffuse fibrosis and the other at 
1.61 distinguishing diffuse fibrosis from dense fibrosis [23]. 
These thresholds were since adjusted by the same group to 
one IIR threshold of 1.2 based on EAM-data distinguish-
ing fibrotic from healthy atrial wall [29, 30] with reference 
to a histopathological study by Harrison et al. suggesting 
new voltage thresholds for EAM [22]. These studies did 
not include any healthy volunteers and hence only rely on 
patients with pathologic atrial conditions but agree remark-
ably with the results from the present study.
CMR determination of LA LGE seems very promising 
[4, 8, 31, 32]. However, there a differing reports from dif-
ferent centres [5, 33], suggesting that CMR imaging of LA 
LGE needs to be streamlined with regards to image acquisi-
tion and analysis method. More widespread use of LA LGE, 
in research as well as clinically, depends on optimization 
of imaging parameters [6, 34] and objectification of imag-
ing analyses [5, 12, 22, 23, 25, 35]. Consensus on imaging 
parameters and analysis method would make results of clini-
cal studies more robust. Once there is a general agreement 
on how to perform LA LGE, results from different studies 
can be pooled and provide better foundation for clinical work 
[21].
Increased degree of native pre-ablation atrial fibrosis has 
been associated with age [9, 12, 32, 36], higher CHADS-
score [12], hypertension [4, 12], stroke [24, 31], persistent 
AF [18, 20, 26, 36], re-entrant activity [8] and increased 
recurrence rates after ablation [4, 8, 10–13, 37]. The 
Table 2  Cardiovascular 
magnetic resonance data
LV left ventricle, EF ejection fraction, EDVi indexed end-diastolic volume, ESVi indexed end-systolic vol-
ume, LA left atrium, IIR image intensity ratio








LV EF (%) 62.8 ± 5.4 61.0 ± 3.5 63.5 ± 12.2 0.74
LVEDVi 96.8 ± 11.2 96.7 ± 11.6 87.0 ± 19.1 0.20
LVESVi 36.3 ± 8.0 37.7 ± 5.5 33.5 ± 19.9 0.74
LA max volume indexed 57.6 ± 9.5 52.6 ± 11.2 54.2 ± 8.7 0.48
LA min volume indexed 24.9 ± 5.3 22.4 ± 5.6 26.9 ± 5.9 0.18
Left atrial late gadolinium enhancement
 Mean IIR 0.96 ± 0.13 1.00 ± 0.14 1.05 ± 0.21 <0.0001
 Degree of fibrosis (IIR > 1.2) 2.8% (1.3–8.3) 9.0% (3.9–12.0) 20.1% (10.2–35.8) 0.001
 Skewness 0.16 0.20 0.70
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suggested associations between atrial fibrosis and age as well 
as with various comorbidities is continuously debated, since 
other studies have not found associations [20, 30, 38, 39].
Our results show that patients with lone AF have higher 
degrees of atrial fibrosis compared to age-matched healthy 
volunteers. These patients have no detectable structural heart 
disease and all included patients had paroxysmal AF, pos-
sibly the form with the least electrical and structural remod-
elling, which was also reflected by similar findings in other 
CMR parameters. It should especially be noted that atrial 
dimensions were similar in all three groups. This suggests 
that AF itself is associated with increased degree of fibro-
sis independently of structural remodelling, which is also 
supported by other studies [11, 25, 36, 39]. The question 
remains though, whether the fibrosis is the cause of AF or 
vice versa. In an elderly patient group with no history of 
AF but varying presence of diabetes mellitus, hypertension, 
congestive heart disease and/or previous stroke we found 
significantly higher degrees of fibrosis compared to both 
young groups.
The fibrotic atrial cardiomyopathy (FACM) concept of 
Kottkamp [38] explains the increased degrees of atrial fibro-
sis in lone AF patients but although studies are scarce, there 
is evidence that the degrees of fibrosis increase with age and 
presence of structural heart disease in patients without AF 
[36] and it may be that there are several different mecha-
nisms that result in atrial fibrosis. The existence of a FACM 
syndrome does not rule out that diffuse atrial fibrosis can 
develop over time and possibly be augmented by various 
comorbidities. The question remains whether patients with 
increased degrees of fibrosis of any source are more likely to 
develop AF compared to patients without fibrosis.
Study limitations
The study is based on a relatively small number of patients 
and healthy volunteers but nevertheless provides a repro-
duction of the same IIR threshold value as found by Benito 
et al. [25]. In general, the IIR method has not been validated 
against tissue samples but only EAM. While it would have 
strengthened the results with a further EAM-validation, this 
would not have been ethically responsible since the study 
was performed on healthy volunteers.
Fibrosis is a dynamic process stretching from initial 
inflammation and ultimately potentially development of 
scar, i.e. stable fibrotic tissue. As in all LGE studies, there 
is the possibility that visualised LGE in fact reflects early 
inflammatory processes/oedema in the myocardium and not 
stable fibrotic tissue [40], hence enhancement may instead 
be termed suspected fibrosis.
We decided to only test the threshold distinguishing 
between healthy and fibrotic atrial wall since this separation 
is clinically relevant and we have found no studies suggest-
ing further value of two thresholds.
The thickness of the atrial wall is close to the resolution 
of CMR and hence especially for thin in-plane structures the 
3D-acquisition can provide low accuracy and some degree 
of partial volume effects may be unavoidable.
While some studies find no correlation between age and 
increased fibrosis [8, 20, 26, 38] and others do [9, 12], we 
decided to set an upper age-limit at 45 years to avoid pos-
sible age-related fibrosis in healthy volunteers.
With regards, to the elderly non-AF population, there is 
the possibility that they have experienced asymptomatic AF 
episodes.
Conclusion
In 1.5T LA LGE scans on healthy volunteers we found an 
IIR threshold of 1.21 for healthy versus fibrotic tissue which 
is similar to the previously found threshold of 1.20 in 3T 
scans. The IIR threshold between healthy and fibrotic atrial 
myocardium of 1.2 can thus be used for both field strengths.
Using the IIR threshold of 1.20, we found increased 
degrees of left atrial fibrosis in patients with lone paroxys-
mal AF compared to healthy controls in the same age-range. 
Elderly patients with no known history of AF but known dia-
betes mellitus, hypertension, congestive heart disease and/or 
previous stroke had significantly higher degrees of left atrial 
fibrosis than both groups of younger individuals.
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